rs7652179: Understanding Its Link to Chronic Pain
The genetic variant rs7652179 is a single nucleotide polymorphism (SNP) located in a non-coding, intergenic region of the human genome. It has been identified in large-scale genome-wide association studies (GWAS) as being statistically associated with an increased susceptibility to chronic pain in individuals of European ancestry.
What each genotype means
Baseline pain susceptibility
This genotype represents the baseline state for this variant in many populations. Research into chronic pain susceptibility is ongoing, and current evidence linking this specific variant to pain traits is limited, meaning this result should not be used to predict personal health outcomes.
This is a common genotype found in European populations.
Baseline pain susceptibility
This genotype represents a heterozygous state for this variant. Because the association between this variant and chronic pain is considered limited and based on broad population-level studies, this result does not provide a clear indication of individual pain sensitivity or risk.
This is a common genotype found in European populations.
Baseline pain susceptibility
This genotype represents the presence of the minor allele at this location. While this variant has been identified in large-scale studies as a potential marker for chronic pain susceptibility, the evidence remains limited and does not support using this information for clinical diagnosis or individual risk assessment.
This is a common genotype found in European populations.
What is rs7652179 and Where is it Located?
A SNP, or "snip," is a variation at a single position in the DNA sequence among individuals. The variant rs7652179 is located in an intergenic region, meaning it resides in the long stretches of DNA that exist between genes. Because it is intergenic, this variant does not code for a protein itself, nor is it a part of a specific gene's instructions. Instead, researchers often look at such variants to see if they might influence how nearby genes are regulated or expressed, potentially affecting biological pathways. In the context of genomic research, "intergenic" variants like rs7652179 are frequently highlighted because their location provides a target for further study to understand the complex genetic architecture of common, multifaceted health conditions like pain.
Understanding the Research Association
The evidence linking rs7652179 to chronic pain is derived from population-level statistical associations observed in large cohorts, such as the All of Us Research Program. In these studies, researchers compare the genomes of thousands of people with chronic pain against those without it to identify markers that appear more frequently in the affected group. Current findings indicate that rs7652179 reached genome-wide significance in specific analyses of individuals of European ancestry. However, it is important to note that the evidence remains limited. Chronic pain is a highly complex, polygenic trait—meaning it is influenced by many different genetic variants, as well as significant environmental and lifestyle factors. While rs7652179 is a "lead SNP" in certain studies, it represents only one small piece of a much larger, intricate puzzle. It is not a diagnostic marker and cannot predict with certainty whether an individual will experience chronic pain.
What You Can and Cannot Do With This Information
It is critical to understand that genomic data regarding rs7652179 is for educational purposes only. You cannot and should not use this information to diagnose yourself with a medical condition or to guide treatment decisions. Because chronic pain is influenced by many factors—including environment, trauma, and other genetic markers—having a particular genotype for this SNP does not mean you will or will not develop pain-related conditions. If you are experiencing pain, please consult a healthcare professional. They are the only ones qualified to interpret your symptoms and clinical history. If you are ever prescribed medication for pain management, always discuss the dosage, potential side effects, and your overall treatment plan with your clinician or pharmacist to ensure it is appropriate for your specific needs.
How common is this variant?
The variant rs7652179 is considered common in European populations. In large-scale genetic databases, such as those curated by gnomAD, researchers observe variations in allele frequencies across different ancestral groups.
Frequently asked questions
Is rs7652179 a diagnostic test for chronic pain?
No. This SNP is a statistical marker identified in population studies; it is not a diagnostic test for chronic pain or any pain-related disorder. Genetics is only one factor, and clinical diagnosis is based on physical examinations and history.
Can I change my rs7652179 genotype?
No. Your genetic sequence is inherited and remains constant throughout your life. However, having a specific genotype does not dictate your health outcomes, as lifestyle and environmental factors play a major role in pain management.
Should I be worried if I have the 'risk' allele?
No. Most people carry various genetic variants associated with different traits. A statistical association in a research study does not mean that you are destined to experience chronic pain, nor does it imply a specific medical risk for you as an individual.
Where can I find more information on my own genetic data?
If you have participated in a genetic testing service, you can often view your raw data through their portal. However, always be cautious when interpreting such data and consult a genetic counselor or your doctor if you have specific concerns about your health.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7652179?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant is a significant risk factor for the development of Gaucher disease and Parkinson's disease.
This variant is associated with cystic fibrosis, affecting chloride channel function in epithelial cells.
This variant is a known pathogenic mutation contributing to hereditary breast and ovarian cancer syndrome.
This pathogenic variant is strongly associated with an increased lifetime risk of breast and ovarian cancer.
A polymorphism identified as a predictive biomarker for clopidogrel response in a multi-gene NGS panel study.
A variant significantly associated with clopidogrel responsiveness in diverse populations, highlighting the importance of transethnic genetic studies.